Detalhe da pesquisa
1.
Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad.
Bull World Health Organ
; 92(2): 86-92, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24623901
2.
Implementing a Birth Dose of Hepatitis B Vaccine in Africa: Findings from Assessments in 5 Countries.
J Immunol Sci
; Suppl(5): 31-40, 2018 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30931434
3.
Elimination of Epidemic Meningitis in the African Region: Progress and Challenges: 2010-2016.
J Immunol Sci
; Suppl: 41-45, 2018 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761390
4.
Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
Vaccine
; 35(49 Pt B): 6866-6871, 2017 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132994
5.
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.
Vaccine
; 30 Suppl 2: B40-5, 2012 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22607898
6.
Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad
Bull. W.H.O. (Print)
; 92(2): 86-92, 2014-2-01.
Artigo
em Inglês
| WHOLIS | ID: who-271459